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strated hmportant differences in diabetic patients with auto- 
nomic dysfunction. The diabetic patients with modcrate to 
severe autonomic dysfunction did not experience the morning 
peak in ischemic episodes, and the transient ischemic episodes 
were evenly distributed throughout the day. However, the 
findings reported in this study should be considered prelimi- 
nary observations because of the small number of patients 
r-valuated. If confirmed by larger studies, such findings could 
potentially provide new insight into the mechanism of the 
circadian rhythmicity of cardiac events. For cxamplc, the lack 
of morning incrcasc in the risk of myocardial ischemia in 
diabctir: patients with a~iton~~~~i~ dysfunction compared with 
thr preserved circadian rhythm in patients without autonomic 
dysfunction, indirectly suggests that the morning surge in 
sympathetic activity dots indeed plihy a signilicant role in the 
pathogcncncsis of transient ischcmic cpisodcs. The results of 
previous studies [ 12-14) that evaluated chtmgcs in heart rittc 
and blood pressure as a surrogate of the lcvcl of sympathetic 
activity, demonstrated that the morning incrcasc in ischrmic 
cpisodcs is accompanied by paraltcl increases in heart rate and 
blood pressure, suggesting a pathogcnctic role of hcightcned 
sympathetic tone for coronary cvcnts in the morning. 
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Since trncicnt times, anecdotal cxpcricnccs such as that CIC- 
scribed in the cpituph found in Scvcnoaks churchyard, En- 
gland, have been cited to illustrate the increased risk of sudden 
death in the morning, Howcvcr, it was not until the work by 
Mullcr ct ill. (2,3) that the circadian pattern of xutc mycmr- 
dial infarction and sudden cardiac death was established. 
Subsequently, a s&s of reports, mostly evaluating small 
numbers of patients, dcmonstratcd a diurnal pattern of coro- 
nary events, including transient myocardial ischemia, acute 
myt~ardial infarction and sudden cardiac death with a peak in 
the morning hours (4-17). Two reports published in this issue 
of the Journal further emphasize the importance of the 
circadian pattern of coronary events hy oxtcnding previous 
observations in new s&sets of patients with cardiac disease 
(18.19). In the first report. Znrich et al. (18) evaluated the 
prevalence and pattern of ambul;itoty myocurdial ischcmia and 
the rule of au&nomic dysfunction in diabetic patients; in the 
second, Moser ct al. (19) dcmonstratcd the circadian pattern 
of sudden cardiac death in pnticnts with advanced heart 
ftbilure. 
Prwxnt studits The findings rcportcd hy Zarich ct al. (N), 
with regard to the overall prcvalcncc and circadian pattern of 
ambulatory myocardhl ischcmia in diabetic paticntts, are in 
arxwrd with several previously published reports of patients 
with coronary artery disease (12-16). However, the authors 
have provided considerable new information by evaluating the 
potential role and relationship of autonomic dysfunction to the 
time of ischpmic episodes during daily life. Although Zarich et 
al. (18) O~SWN~, in their patient group as a whole. a circadian 
pattern of mywardirrl iwhen& with a significant increase in 
the risk of dcvcloping ischcmia in the morning, they demon- 
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The study by Zarich et al. (18) does have some shortcom- 
ings that could influence their results. More than 37% of the 
patients participating in the study undcrwcnt i~n~bulatl~~ elcc- 
trocardiographic (ECG) monitoring while taking their antian- 
ginat drugs, which would undoubtedly attcr the frequency of 
ischcmia compared with the remaining group who were not 
taking anti-ischcmie drugs. In contrast, the evaluation of 
autonomic nervous system function in patients with ischcmia 
ws performed after discontinuation of all antianginat mcdi- 
cation. The differing circumstances under which the amhula- 
tory EC6 monitoring and the status of autonomic nervous 
system function were evaluated could influence the findings 
reported in patients with autonomic dysfunction. Finally, the 
role of potenCti: : riggers cannot be evaluated because no 
information is provided itbout wakeup times, postural changes 
and activity levels during the monitoring period. Despite these 
minor limitations, the findings reported are of clinical rete- 
Vance and lend further support for the need to conduct future 
studies with careful evaluation of the rote of sympathetic tone 
and other potential triggers in the pathogenesis of coronary 
events. 
In the second study, the findings described by Moser et al. 
(l9), in a large group of patients with advanced (New York 
Heart Association class III or IV) heart failure, highlight the 
importance of the timing of sudden cardiac death, regardless of 
the underlying cardiac discasc. Although the circadian pattern 
of sudden death in patients with coronary artery disease and 
myocardial infarction has been previously reported by several 
investigators (3-g), the study by Moser et al. (19) is the first 
report that documents the morning increase in the risk of 
sudden death in patients with heart failure. The determination 
of the precise cause of death in patients with heart failure is a 
challenging task because of the inherent problems in distin- 
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g~isbi~~ ricath due to pump failure fro 
t likely secondary to Ii 
wever, in the present stu 
t to exclude deaths due to pump Fzeilurc 
otbcrwise stable 
patients with heart failure. Similar to the results described in 
previous reports (20). nearly 50% of those dying during the 
l&month follow-up period in the present study experienced 
sudden cardiac death (19). Forty-six percent of the deaths 
occurred between 6 AM and noon, accounting for a 2.5fold 
increase in the risk of sudden death in the morning hours 
compared with tbc other three 6-h time blocks of the day. 
Patients dying suddenly had a lower ejection fraction com- 
pared with patients in other groups. There was also a trend 
toward a greater pcrccnt of patients with sudden death for 
USA: of digitalis, nitrates and ;I~~tii~rri~yth~~~ic drugs, suggesting 
IhaI those dying suddenly mljst likely hd WOTSC discasc or 
cncountercd advcrsc cffccts of thcsc drugs. Another intcrcst- 
ing observation in this report is thilt il sipnilicantly IilrgCl 
pcrcenl of surviving patients wcrc rccciving imgiOlcilSil~- 
converting enzyme inhibiting agents compared with those 
dying suddenly, providing indirect evidence for the beneficial 
role of angiotensin-converting enzyme inhibitors in reducing 
the risk of sudden cardiac death, a phenomenon also prcvi- 
ously reported in other studies (19,20). Whether trcatmcnt 
with angiotensin-converting enzyme inhibitors decrcascs the 
risk of sudden death by reducing tbc density of potentially 
lethal cardiac arrhythmias or by improvement in cardiac 
performance, correction of cellular electrolyte imbalance or 
the favorable changes in the neurohormonal axes has not yet 
been well studied and dcscrves further evaluation. 
One of the main shortcomings of the study by Moser cl al. 
(19) is the lack of information about the time of suddcu death 
for >2S% of the patients. This could potentially introduce a 
bias in favor of the circadian rhythm of sudden death bccausc 
it is not inconceivable that most of the unwitnessed sudden 
deaths occurred during sleep. Another drawback of the study is 
the lack of information with regard to the relationship of 
sudden death to the time of awakening and any changes in 
pqsturc or level of activities. The results would also have been 
more meaningful if the authors had provided some new insight 
into the mechanism of the morning increase in the risk of 
sudden death, such as increase in cardiac arrhythmias or 
altered electrophysiologic properties secondary to morning 
surges in sympathetic tone. Because of these limitations, the 
precise mechanism responsible for the morning increase in the 
risk of sudden death in patients with heart failure cannot be 
identified. However, the potential mechanisms may include 
increased density of arrhythmias or coronary events due to the 
enhanced sympathetic tone, during the morning hours (21,22). 
Although no direct evidence is available to support these 
postulates, data from previous studies suggesting a beneficial 
role of beta-adrenergic blocking agents in reducing the risk of 
sudden death in postinfarction patients with congestive heart 
failure do indirectly suggest that the enhanced sympathetic 
in increasing the risk of sudden 
Several previous studies (2-15) 
nsient rnyocardial is&mia and 
iKJUtC coronary events have a definite circadian pattern, witlr a 
cluttering of ischemic events in the morning hours between 
6 AM and noon. A number of recent studies (9-11) have con- 
firmed the original findings reported by fvsuller et al. (2) by 
demonstrating the circadian pattern of acute my(jcardial infarc. 
iion, as determined by a detailed record of patient symptoms and 
the time-activity patterns of cardiac enzymes. Studies conducted 
with stable coronary artcry disease, evaluated by 24 to 
r ambulatory ECG monitoring, have also shown that 
cpisodcs of trimsicnt myocardial ischemia demonstrate a circa- 
dials pattern similar to that described for acute myocardial 
infarction and suddcll death (12-16). However, the findings 
reported in m;my of the previous studies wcrc of limited value 
bccaUsc most studies wcrc: conducted in small, sclcctcd groups of 
patients, and littlc dbrt was made to clucidatc the pathogen&c 
mechanisms involved. The preliminary results of a rcccnt large” 
scale ClilliCill triill (17) in pihlts with stable coronary artq 
disease and minimal or no symptoms have shown that the risk of 
transient ischemia is clearly increased in the morning and that 
ischemic activity dots indeed have a circadian rhythm similar to 
other coronary cvcnts. 
Since the original description of the circadian pattern of 
sudden cardiac death by Mullcr ct al. (3), several addirional 
studies (4-K) have evaluated and confirmed the earlier observe- 
tions. Although most of these studies bad dcscribcd the circadian 
pattern of sudden death in patients with acute myocardial infarc- 
tion, two studies published in the Journal within the past 6 months 
have cvaluatcd the diurnal pattern of sudden death in survivors of 
acute myocardial infarction with ventricular arrhythmias (7) and 
in patients with hypcrtrophic obstructive cardiomyopathy (8). 
In a substudy of the Cardiac Arrhythmia Suppression Trial 
(CAST) (7), the time of onset of out-of-hospital arrhythmic 
death was prospectively evaluated to determine whether ant;- 
arrhythmic drugs had altered the circadiiln pattern in patients 
with a previous myocardial infarction who had frequent vcn- 
tricular premature beats. Based on the availability of accurate 
time of the event, the data were available for a total of 138 
victims of sudden deaths (95 patients taking class ic antiar- 
rhythmic agents and 43 patients receiving placebo). Thcrc was 
a bimodal distribution for the onset of arrhythmic deaths with 
significant peaks in the midmorning and late afternoon/early 
evening periods. When corrected for the time of awakening, 
a prominent peak was observed within the initial 2 h in the 
antiarrhythmic group but not in the placebo group. It is 
conceivalylc that the use of cncainidc or flccainidc facilitated 
the risk of arrhythmic deaths in the morning hours when 
sympat]iCtiC activity is enhanced and risk of ischcmic events is 
also increased (7). 
In another study (X), circadian variability of sudden cardiac 
death was evaluated from data available from the National 
Heart, Lung, and Blood Institute (NHLBI) registry of patients 
with hypertrophic cardiomyopathy. Of the I35 patients who 
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had died of sudden death, 94 had reliable data for evaluation. 
In these p_tients, sudden death occurred most commonly 
between 9 and IO AM, and overall, 46% of sudden deaths were 
encountered between 7 AM and 1 PM. There was a less distinct 
but a secondary peak between b and 10 PM. The significant 
increase in the risk of sudden deaths during the morning hours 
in these patients with hypertrophic cardiomyopathy, although 
similar to that reported previously in patients with coronary 
artery disease. is unique and provides new insight into the 
mechanism of diurnal variability of sudden death. Because 
most of these patients had primary myocardial disease and did 
not have coronary artery distww, the morning peak in sudden 
death cannot be attributed to a fatal coronary event. a mech- 
anism frequently thought to bc rcrponsiblc for the circadian 
pttcrn of sudden death in patients with coronary artery 
d&se. Furthermore, the strong association between sudden 
death and the level of physicul activities preceding the fatal 
event sts that physical stress acted as a potential trigger 
for su death in these patients (8). The findings of this 
study also underscore the need for an evaluation of potential 
and related physiologic changes with the goal of 
anding the mechanism of onset of acute cardiovascular 
disorders. 
Role of timiag vw!4us tri m. Although most previous 
studies in this field concentrated their efforts to define the 
timing of coronary events and sudden cardiac death, several 
recent reports (23-26) have carefully evaluated the role of 
potential triggers in an effort to understand the mechanism of 
acute disease onset. The identification of specific triggers 
leading to acute coronary events is ab.solutely essential to 
develop therapy targeted for prevention of these cvcnts {26). 
The results of these studies have indicated that symptoms of 
acute myocardial infarction occur most frcqucntly within the 
initial 2 h after awakening and resumption of upright posture 
(23-25). Because most patients evaluated in these studies 
apparently had normal sleeping patterns, it should not bc 
surprising that the increased risk within the first few hours after 
awakening or after resumption of upright posture, coincided 
with the morning time. However, it would he of interest to 
examine whether the timing of cardiac events changes with 
altered sleep patterns, such as those encountered by night-shift 
workers. RLwnt studies (2425) have also cmphasizcd the 
importance of physical activities as potential triggers of acute 
coronary events. The results of these studies revealed that the 
risk Of a myocardial infarction is significantly increased in 
association with strenuous physical activity, particularly in 
sedentary patients. 
The mle of potential triggers has also been evaluated in 
association with sudden cardiac death. As discussed earlier, the 
results from CAST (7) in patients dying suddenly indicated 
that the greatest risk of sudden death was observed within the 
first few hours after awakening. In the NHLBI report by 
Maron et al. (8). the association between heavy physical 
exertion and the increased risk of sudden death in patients with 
Mrtmphic cardiomyopathy was of interest because it also 
identified a potential trigger in a group of patients with a 
nonischemic but primary myocardial disease process. Prelimi- 
nary observations in experimental studies suggest that mental 
stress and anger can also act as potential triggers because of 
the associated increased myocardial vulnerability, as demon- 
stratcd by T wave alternans and other measures of cardiac 
repolarization (27). 
It is likely that strenuous physical activities and mental 
stress, act in concert with the heightened sympathetic tone as 
potential triggers of the coronary events in the morning. 
Several other physiologic variables also show significant 
changes in association with awakening, changes in posture, 
strenuous physical activities and stress (26). These 
changes include increased catcchol onccntration levels, 
increased heart rate and blood prcssuro, increased vascular 
resistance, enhanced platelet a~rcgability, reduced intrinsic 
fihrinolytic activity and altcratiotrs in various other l~~~rrn~~ll~~l 
Icvels. Although these changes arc all important, it is not yet 
prcciscly known which of these alterations play a ~loi~li~a~t 
role in the genesis of coronary events. Future rcscarch should 
focus on isolating the specific factors that can trigger a given 
acute cardiovascular event. On the basis of the available data, 
it stems reasonable to conclude that the presence of a specific 
trigger is more important than a given time of day for the onset 
of coronary events and 
Therapeutic onside rimary purpose of any 
given study, including the two rcportcd in this issue of the 
Sournal, is to better understand the pathophysiologic basis of 
the disease process so that appropriate therapeutic intervcn- 
tion can bc implemented. Because the precise mechanism 
res~nsib~c for the circadian pattern of cardiac events has not 
been well defined, few prospective studies have evaluated the 
role of specific therapeutic interventions. The available data 
from largely retrospcctivc evaluations indicate that patients 
rccciving beta-blocker therapy seem to have less prominent 
increases in the risk of acute myocardial infarction and sudden 
death in the morning hours, Some recent studies (28-30) have 
prospectively evaluated the role of antiischemic drugs in 
suppressing myocardial &hernia, particularly during the morn- 
ing hours. Although the data from these studies have demon- 
strated that beta-blockers are the most effective agents in 
reducing the risk of ischemia d_uring the morning hours, these 
results arc of limited value because most of these studies 
evaluated small numbers of patients and used a variety of drugs 
in different doses. The preliminary results from a large-scale 
prospective trial (31) have recently demonstrated that treat- 
ment with atenolol was highly effective in reducing the morning 
increase in myocardial ischemia in patients with stable coro- 
nary artery disease. Future studies are needed to evaluate 
comparative efficacy of other anti-ischemic drugs in larger 
groups of patients to determine the therapy most effective for 
suppression of ischemia in the morning. It would also seem 
logical for future studies to compare the effects of morning 
versus nighttime administration of drugs because it is likely 
that the drugs given at nighttime would be more effective in 
suppressing the morning surge of myocardial ischemia. Finally, 
it is also essential to demonstrate that the therapy effective in 
the hvo pubkhed in this issu- c of the Journal, have clearly 
that these is ;1 ~~~~~~i~~ surge in coronary events 
ath. Some recent studies (24,259 have suggested 
that it is not the time 
activities, that triggers t 
i~fQrrnati~~ is availah! 
iologic process involved. There is a need for studies designed 
to explore the mechanisms responsible for triggering the 
cardiac events in the morning hours. without a clear under- 
stal~dil~g of the patho ysiologic process responsible for the 
onset of acute corona events, it is not possible to design a 
t~le~i~~e~ltic strategy for the prevention of acute myocardial 
infarction and sudden death. In recent years, considerahlc 
Cl3lpllitSiS lItIs hcell plX_Xd 011 dcvcloping newer strategies (c,g.. 
thromholytic therapy) for the trcatmcnt of patients ilftcr tlw 
onset of acute myocardia infbction. Although HO one argues 
that early il~tcrv~l~t~~)l~, c ccially LllC irdmiulis~ri~ti()n Of tllRMN- 
holytic therapy, is high ciiicacious in ~cduciilg short- and 
long-term morbidity and mortality after acute myocardial 
infarction, it seems logical that it would also be useful to 
develop therapeutic stratqies designed to prevent the very 
onset of myocardial infarction. This is particularly relevant and 
clinically important because some patients with acute myocar- 
dial infarction never make it to the hospital at all; of the other 
patients who are fortunate enough to arrive at a medical 
facility, only 20% to 30% receive thrombolytic therapy. 
Clearly, there is a well justified and a rather long overdue need 
for well focused research designed to understand and prevent 
the onset of acute cardiovascular cvcnts. It seems fitting to 
conclude by reminding ourselves that “an ounce of prcvcntion 
is bcttcr than a pound of curt.,” 
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